Catalyst sues FDA over rivals' drug approval, warning it undermines incentives for rare disease meds - STAT

Catalyst sues FDA over rivals' drug approval, warning it undermines incentives for rare disease meds - STAT

More reads

• Catalyst sues FDA over rivals’ drug approval, warning it undermines incentives for rare disease meds. (STAT Plus)
• Move over, Martin Shkreli: This pharma exec is accused of fixing prices on 107 drugs. (Forbes)
• Bain Capital raises $900 million for second life sciences fund. (Bloomberg)
• House progressives challenge drugmakers to come back to Capitol Hill. (STAT)